Human Oncology & Pathogenesis Program

The Vinod Balachandran Lab

Share
Print
Back to Top

Research

Pictured: Dr. Vinod Balachandran
Vinod Balachandran, MD
Member, David. M Rubenstein Center for Pancreatic Cancer Research

Assistant Professor

Our goal is to discover new ways to stimulate the immune system to treat cancer through careful study of rare cancer patients with exceptional outcomes. We believe that deep study of these remarkable patients will identify fundamental mechanisms of how the immune system controls cancers, and accelerate the discovery of new effective drugs. We use this approach to study pancreatic cancer, a model deadly cancer that is refractory to all treatments including immunotherapy – and specifically focus on a rare subgroup of pancreatic cancer patients with exceptional long-term survival to discover new immunotherapeutic approaches. Our long-term vision is to use a similar approach of study of biological extremes to usher in the next generation of cancer immunotherapies.

The Vinod Balachandran Lab

Featured News

In the Lab
Surgeon-scientist Vinod Balachandran
What’s Next in Immunotherapy for Pancreatic Cancer? New Immune Cell Type May Be Key

Finding
An illustration of the human pancreas
Why Do Some People Beat the Odds against Pancreatic Cancer?

Publications

Moral JA, Leung J, Rojas LA, Ruan J, Zhao J, Sethna Z, Ramnarain A, Gasmi B, Gururajan M, Redmond D, Askan G, Bhanot U, Elyada E, Park Y, Tuveson DA, Goen M, Leach SD, Wolchok JD, DeMatteo RP, Merghoub T & Balachandran VP. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. Nature. 2020 Feb 19.  https://doi.org/10.1038/s41586-020-2015-4

Balachandran VP, Łuksza M, Zhao JN, Makarov V, Moral JA, Remark R, Herbst B, Askan G, Bhanot U, Senbabaoglu Y, Wells DK, Cary CIO, Grbovic-Huezo O, Attiyeh M, Medina B, Zhang J, Loo J, Saglimbeni J, Abu-Akeel M, Zappasodi R, Riaz N, Smoragiewicz M, Kelley ZL, Basturk O; Australian Pancreatic Cancer Genome Initiative; Gönen M, Levine AJ, Allen PJ, Fearon DT, Merad M, Gnjatic S, Iacobuzio-Donahue CA, Wolchok JD, DeMatteo RP, Chan TA, Greenbaum BD, Merghoub T, Leach SD. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Nature. 2017 Nov 8. doi: 10.1038/nature24462. [Epub ahead of print]. PMID: 29132146

Łuksza M, Riaz N, Makarov V, Balachandran VP, Hellmann MD, Solovyov A, Rizvi NA, Merghoub T, Levine AJ, Chan TA, Wolchok JD, Greenbaum BD. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy. Nature. 2017 Nov 8. doi: 10.1038/nature24473. [Epub ahead of print]. PMID: 29132144

Balachandran VP, Cavnar MJ, Zeng S, Bamboat ZM, Ocuin LM, Obaid H, Sorenson EC, Popow R, Ariyan C, Rossi F, Besmer P, Guo T, Antonescu CR, Taguchi T, Yuan J, Wolchok JD, Allison JP, DeMatteo RP. Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nature Medicine. 2011 Aug 28;17(9):1094-100. doi: 10.1038/nm.2438. PMID: 21873989

View All Publications

People

Pictured: Dr. Vinod Balachandran

Vinod Balachandran, MD

Member, David. M Rubenstein Center for Pancreatic Cancer Research

Assistant Professor

  • Surgeon scientist Vinod Balachandran develops novel immunotherapies for pancreatic cancer.
  • MD, State University of New York at Stony Brook
212-639-5785
Office Phone
View physician profile
Physician profile

Members

Masataka Amisaki

Research Scholar

Kaitlin A. Aviles
Kaitlin Aviles

Office Coordinator

Pablo Guasp Baratech
Pablo Guasp Baratech

Research Fellow

Adrienne Chandra
Adrienne Chandra

Research Technician

Zagaa Odgerel
Zagaa Odgerel

Lab Manager

Luis A. Rojas

Research Fellow

Zachary Sethna, PhD
Zachary Sethna

Research Scholar

Rebecca Yu

Research Technician

Abderezak Zebboudj
Abderezak Zebboudj

Research Fellow

Lab Alumni
Christian Brodala

Administrative Assistant

Joanne Leung, Ph.D.
Joanne Leung

Postdoctoral Research Scholar

John Alec Moral

Postdoctoral Research Fellow

Karina Ng
Karina Ng

Summer Student 2018

Jenni Ruan

Research Technician

Julia Nanyi Zhao

Research Technician

Lab Affiliations

Achievements

  • Pershing Square Sohn Prize (2020)
  • Society of Immunotherapy for Cancer Presidential Award (2017)
  • National Cancer Institute Cancer Moonshot Award (2017)
  • Damon Runyon Clinical Investigator Award (2017)
  • AACR/Pancreatic Cancer Action Network Career Development Award (2017)
Read more
  • NCI Paul Calabresi Career Development Award (2016)
  • Society of Surgical Oncology Harvey Barker Award (2015)
  • David and Monica Gorin Fellow Award (2013)
  • Memorial Sloan Kettering Chairman’s Award for Best Basic Science Research (2010)
  • Society of University Surgeons Research Fellowship Award (2009)
  • Alpha Omega Alpha

Lab News & Events

Open Positions

Postdoctoral Fellow

Apply now

Get in Touch